IV BioHoldings (IVBH) is a precision health company specializing in liquid biopsy technologies that radically improve the detection, diagnosis and treatment of life-threatening disease. Our novel decentralized business model is defined by speed, efficiency and risk management, made possible through advanced data science, exponential technologies, powerful partnerships and several decades of combined multi-disciplinary expertise. The current IVBH ecosystem consists of three specialty precision health companies and an expansive pipeline of clinical-stage diagnostics addressing unmet needs across the care continuum for lung cancer, liver disease and breast cancer. Our first-in-class patented and patent-pending technologies are designed to complement and enhance existing standards of care through an advanced integrative diagnostic ensemble — ruling more of the right patients into imaging and intervention earlier and reducing unnecessary procedures that are invasive, risky, expensive and stressful. For more information visit www.IVBH.studio.